Want to see SURG full AI Analyst Report?
SURG Stock Chart & Stats
$0.24
-$0.01(-5.08%)
At close: 4:00 PM EDT
$0.24
-$0.01(-5.08%)
Day’s Range― - ―
52-Week Range$0.20 - $3.14
Previous CloseN/A
Volume461.58K
Average Volume (3M)365.02K
Market Cap
$6.20M
Enterprise Value$30.84
Total Cash (Recent Filing)$2.42M
Total Debt (Recent Filing)$15.51M
Price to Earnings (P/E)―
Beta0.74
Next Earnings
Nov 17, 2026EPS Estimate
-0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.93
Shares Outstanding25,121,895
10 Day Avg. Volume122,567
30 Day Avg. Volume365,018
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)-2.18
Price to Sales (P/S)0.59
P/FCF Ratio-1.57
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit>-0.01
Enterprise Value/Ebitda>-0.01
Forecast
1Y Price Target
$3.50Price Target Upside1358.33% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)-0.44
Revenue Forecast (FY)$71.20M
Bulls Say, Bears Say
Bulls Say
High Revenue GrowthSustained top-line expansion (55.8% revenue growth) signals the company is scaling its MVNO/Lifeline and POS offerings into underserved prepaid channels. Durable revenue momentum supports operating leverage potential if unit economics are improved and can underpin multi‑quarter growth opportunities.
Redline JV Expands DistributionForming Redline Wireless (51% owned, consolidated) gives SurgePays exclusive rights to a national network of 20,000+ independent dealers and uses its MVNO platform and back office. This structural, low‑cash distribution expansion can materially broaden customer reach and channel scale over months.
AT&T Agreement AmendedEliminating $50M minimum spend commitments and securing ~$10.3M forgiveness reduces cost of acquisition and accounts payable. This materially improves near‑term margins and balance sheet headroom and creates a lasting improvement in wholesale pricing and unit economics if sustained.
Bears Say
Negative Gross ProfitNegative gross profit indicates the core business cannot currently cover direct costs, pointing to broken unit economics. Unless pricing, wholesale costs, or product mix change materially, persistent negative gross margins will continue to erode operating performance and require external capital or restructuring.
Negative Stockholders' EquityA shift from positive equity to negative equity signals accumulated losses have depleted the capital base. This structurally raises refinancing and covenant risk, constrains strategic flexibility, and increases likelihood of dilution or distress if profitability recovery is not achieved over the medium term.
Reliance On Convertible DebtOngoing reliance on secured convertible notes (tiered conversion, interest, junior liens) reflects continued cash burn and external financing needs. This financing profile increases dilution and credit risk over time and suggests the company may face repeated capital raises absent sustainable positive cash flow.
SurgePays News
SURG FAQ
What was SurgePays’s price range in the past 12 months?
SurgePays lowest stock price was $0.20 and its highest was $3.14 in the past 12 months.
What is SurgePays’s market cap?
SurgePays’s market cap is $6.20M.
When is SurgePays’s upcoming earnings report date?
SurgePays’s upcoming earnings report date is Nov 17, 2026 which is in 93 days.
How were SurgePays’s earnings last quarter?
SurgePays released its earnings results on Aug 06, 2026. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of -$0.11 by $0.16.
Is SurgePays overvalued?
According to Wall Street analysts SurgePays’s price is currently Undervalued.
Does SurgePays pay dividends?
SurgePays does not currently pay dividends.
What is SurgePays’s EPS estimate?
SurgePays’s EPS estimate is -0.08.
How many shares outstanding does SurgePays have?
SurgePays has 25,121,895 shares outstanding.
What happened to SurgePays’s price movement after its last earnings report?
SurgePays reported an EPS of $0.05 in its last earnings report, beating expectations of -$0.11. Following the earnings report the stock price went up 45.74%.
Which hedge fund is a major shareholder of SurgePays?
Currently, no hedge funds are holding shares in SURG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
SurgePays
SurgePays, Inc. (SURG) is a financial-technology and telecommunications-focused company that provides wireless connectivity and fintech/merchant services aimed primarily at underserved and prepaid customer segments. The company operates through offerings that include prepaid wireless services and related distribution/enablement solutions, and it also provides services and software that support transactions for retailers and consumers in the prepaid and convenience-store ecosystem.
SURG Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
The call mixed clear operational progress and cost discipline with material liquidity and transition risks. Highlights include demonstrated scalability (notably Q2->Q3 +62.6%), significant cost cuts (G&A and SG&A down ~27%), improved gross loss (~25.9%) and operating loss (~26.6%), strong point-of-sale/prepaid growth (+$26.1M YoY) and diversification across multiple revenue channels with a >9,000 location footprint. Lowlights include a full-year revenue decline (~6.4%), a Q3->Q4 sequential revenue decline (~13.4%) driven by reduced acquisition spend, low year-end cash (~$1.7M) and a working capital deficit (~$16.2M), substantial operating cash use (~$21.3M for 2025) and continued dependence on financing (~$10.5M raised). Management outlined actions to lower monthly burn to ~$250K–$300K and emphasized showing progress in 2026, leaving the call balanced between meaningful improvements and notable liquidity/execution risks.View all SURG earnings summariesSURG Stock 12 Month Forecast
Average Price Target
$3.50
▲(1358.33% Upside)
Technical Analysis
Ownership Overview
9.44% Insiders
2.92% Mutual Funds
3.82% Other Institutional Investors
81.57% Public Companies and
Individual Investors